111 filings
Page 2 of 6
8-K
qv2r p2ab
24 Feb 23
Other Events
7:06am
8-K
e3cnfz2bo z1ciw8wvu6
10 Feb 23
Orchard Therapeutics Announces Proposed ADS Ratio Change
7:26am
8-K
ysbtu61jj
9 Jan 23
Orchard Therapeutics Highlights Recent Progress Across HSC Gene Therapy Portfolio and Outlines Key 2023 Milestones
7:13am
8-K
3k68yskw
5 Jan 23
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
7:05am
8-K
ii548n hrhgv
12 Dec 22
Regulation FD Disclosure
4:22pm
8-K
3ha2 i6mp
14 Nov 22
Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:10am
8-K
gju0ghc13d7e22n4ax21
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
8-K
bbw6p4tb05k 73dw4vk
4 Aug 22
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:05am
8-K
llidgqn4w60nla 6xn
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:00am
8-K
cuklkw5clwlwi
12 May 22
Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress
7:05am
8-K
t24udia2fruwrrpx
8 Apr 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
jf9jjx 02ja
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
qo7ow9x
4 Feb 22
Orchard Therapeutics Announces Historic Agreement Making Libmeldy® Available by NHS England for MLD Patients
7:00am
8-K
lewmzczznw
21 Jan 22
Other Events
7:05am
8-K
o082rgq g120dptfj8
10 Jan 22
Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene Therapy Programs and Outlines Key 2022 Milestones
7:05am
8-K
hwpaezg
18 Nov 21
Orchard Therapeutics Announces New England Journal of Medicine Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome
7:05am
8-K
1bxvkgnx cnee9v
4 Nov 21
Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates
7:50am
8-K
n82jiviv0gj dm9zmgy2
14 Sep 21
Other Events
4:29pm
8-K
zjdhn8
14 Sep 21
Orchard Therapeutics Bolsters R&D and Technical Operations Leadership with New Executive Appointments
7:00am
8-K
zw5mc61 ei1e
4 Aug 21
Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Updates
7:05am